AUS
NZ
UK
CA
USA
IND
Healthcare
Recce Expands R327G Foot Gel Trial with Addition of 20 Participants
April 22, 2025 03:30 PM AEST| By Team Kalkine MediaHighlights,Recce Pharmaceuticals expands its Phase II trial for R327G topical gel with additional participants,Promising clinical responses reported, meeting primary endpoints in diabetic foot infection treatment,Data supports advancement towards reg...
Key Metrics to Evaluate Pro Medicus Ltd (ASX: PME) within the ASX Healthcare Stocks Sector
April 22, 2025 02:53 PM AEST| By Team Kalkine MediaHighlights:,Pro Medicus Ltd (ASX:PME) operates in the healthcare software sector, offering advanced radiology IT solutions globally.,Core metrics such as revenue, gross margin, and profit help assess the company’s financial performance.,The strong fi...
Recce Pharmaceuticals Advances Diabetic Foot Infection Trial, Strengthening ASX Healthcare Stocks Presence
April 22, 2025 02:35 PM AEST| By Team Kalkine MediaHighlights:,Recce Pharmaceuticals receives ethics approval to expand its Phase 2 diabetic foot infection trial.,The therapeutic R327G continues development with additional patients and new data pathways.,Broader efforts in Australia and Indonesia sup...
Mayne Pharma Delivers Strong Earnings Growth Despite Quarterly Headwinds
April 22, 2025 11:51 AM AEST| By Team Kalkine MediaHighlights,Mayne Pharma earnings surged 116% year-to-date,Quarterly sales dip due to weaker dermatology performance,Acquisition by Cosette expected to close this year,Mayne Pharma (ASX:MYX) has reported a substantial earnings rise of 116% for the fin...
Race Oncology Expands RC220 Cancer Trial to Second Australian Site
April 22, 2025 10:41 AM AEST| By Team Kalkine MediaHighlights,RC220 clinical trial opens second site in Australia,Phase 1 aims to assess safety, dosage, and efficacy,Trial includes multiple global locations,Race Oncology (ASX:RAC) has expanded its ongoing Phase 1 clinical trial for RC220, a next-gene...
AI-Powered Health Tech Boosts Women’s Health in Vietnam with TruScreen’s New Screening Initiative
April 22, 2025 10:37 AM AEST| By Team Kalkine MediaHighlights,TruScreen,Group,initiates,a five-year AI-enabled cervical cancer screening drive in Vietnam.,260,000 women to be screened across Ho Chi Minh City under public-private collaboration.,TruScreen,Ultra offers real-time, non-invasive results wi...
Insider Transactions at HITIQ Limited (ASX:HIQ): An Overview
April 21, 2025 02:30 PM AEST| By Team Kalkine MediaHighlights,Insiders have sold more shares than they purchased in HITIQ Limited (HIQ) over the past year.,Otto Buttula made the largest insider sale, significantly above the current market price.,Insiders hold 19% of HITIQ shares, indicating alignment...
Can This ASX Healthcare Stock Sustain Its Momentum on the S&P/ASX 200 and All Ordinaries Indexes?
April 19, 2025 08:30 AM AEST| By Team Kalkine MediaHighlights,The company operates in the healthcare sector and is listed on both the S&P/ASX 200 and All Ordinaries indexes.,Cash expenditure has declined, enhancing its ability to maintain operations over the medium term.,Revenue growth has coincided...
Is ResMed CDI (ASX:RMD) Share Price Undervalued in 2025? Six Metrics That Matter
April 17, 2025 08:36 PM AEST| By Team Kalkine MediaHighlights:,ResMed operates in the medical equipment sector with a global footprint,The company specialises in CPAP systems and healthcare-focused software,Share price has declined since the start of the year,ResMed CDI (ASX:RMD) operates in the medi...
Imricor (ASX:IMR) Gains European Regulatory Nod for Entire Product Line, Readies EU Launch
April 17, 2025 05:42 PM AEST| By Team Kalkine MediaHighlights,Imricor receives CE Mark under new EU regulations,Launch planned in June across Europe,Entire commercial portfolio now MDR-certified,Imricor Medical Systems (ASX:IMR),has secured a significant milestone with the CE Mark approval of its Adv...
Anatara Lifesciences (ASX:ANR) Shares Key Findings from GaRP-IBS Phase II Trial with Promising Safety and Secondary Results
April 17, 2025 05:19 PM AEST| By Team Kalkine MediaHighlights,Phase II trial for GaRP-IBS did not meet primary endpoint,Positive results seen in key secondary measures,Product showed strong safety profile with no concerns,Anatara Lifesciences (ASX:ANR) has announced the results of Stage 2 of its Phas...
Clarity Pharmaceuticals Secures Long-Term Copper-64 Supply from Nusano to Bolster Cancer Therapy Pipeline
April 17, 2025 05:14 PM AEST| By Team Kalkine MediaHighlights,Clarity inks multi-year copper-64 supply deal with Nusano,Nusano’s facility supports large-scale isotope production,Agreement strengthens pipeline for oncology diagnostics and therapies,Clarity Pharmaceuticals (ASX:CU6) has announced the s...
Clarity Pharmaceuticals Expands Theranostics Reach Through Isotope Supply Agreement
April 17, 2025 04:30 PM AEST| By Team Kalkine MediaHighlights:,Clarity Pharmaceuticals secures commercial-scale copper-64 supply agreement with Nusano,Nusano’s Utah facility enhances isotope production for cancer-focused theranostic solutions,Agreement strengthens Clarity’s U.S. clinical pipeline and...
Fonterra Gears Up for Potential IPO with Key Leadership Appointment
April 17, 2025 04:28 PM AEST| By Team Kalkine MediaHighlights,Anne Templeman-Jones joins board of Fonterra’s consumer unit,Strategic move fuels IPO and trade sale possibilities,Consumer arm estimated at up to $4 billion,Fonterra Co-operative Group (ASX:FCG), one of the world’s largest dairy exporters...
Clarity Pharmaceuticals Jumps on Breakthrough US Production Deal for Cancer Imaging Isotope
April 17, 2025 04:04 PM AEST| By Team Kalkine MediaHighlights,Clarity inks commercial production deal for copper-64 with Nusano,Shares rise over 12%, topping ASX 200 leaderboard,$11.1M tax incentive to boost product development,Clarity Pharmaceuticals (ASX:CU6) saw a notable surge in its share price...
Lumos Diagnostics Advances FebriDx® Rollout with Medicare Approval Supporting ASX Healthcare Stocks Momentum
April 17, 2025 02:33 PM AEST| By Team Kalkine MediaHighlights:,Lumos Diagnostics secures reimbursement for FebriDx® through key US Medicare contractors.,FebriDx® test added to national reimbursement schedule, expanding access across clinical settings.,Broader Medicare engagement may strengthen outloo...
InhaleRX initiates Phase 1 trial for inhaler designed to treat panic disorder.
April 17, 2025 01:30 PM AEST| By Team Kalkine MediaHighlights,InhaleRX initiates clinical trials for its cannabidiol-based inhaler therapy, IRX-616a.,Study conducted in Adelaide under the supervision of iNGENū CRO Pty Ltd.,Clendon Biotech Capital provides multi-million dollar funding to support clini...
Lumos Diagnostics Wins Key US Medicare Support for FebriDx®, Eyes Wider Market Reach
April 17, 2025 01:00 PM AEST| By Team Kalkine MediaHighlights,Medicare reimbursement secured for,FebriDx,® in major regions,$41.38 per test rate set to begin from April 2025,Broader US market access expected as discussions advance,Lumos Diagnostics Holdings Ltd (ASX:LDX) has taken a major step forwar...
Dissecting the Shareholder Dynamics of Sonic Healthcare Limited (ASX:SHL)
April 17, 2025 12:34 PM AEST| By Team Kalkine MediaHighlights,Individual investors hold significant influence in Sonic Healthcare Limited (SHL).,Institutions account for a substantial 40% ownership.,Insider ownership is notable with a stake worth AU$137 million.,Understanding the distribution of owne...
Is the Recent Stock Performance of Austco Healthcare Limited (ASX:AHC) Linked to Its Robust Fundamentals?
April 17, 2025 12:32 PM AEST| By Team Kalkine MediaHighlights:,Austco Healthcare (ASX:AHC) displays strong financial indicators with a rising return on equity.,Earnings growth remains solid, exceeding broader industry benchmarks over the long term.,Strategic reinvestment of earnings supports operatio...
Advertise your brand on Kalkine Media